In conclusion, our study suggests that M2c macrophages may exert renoprotective effects by upregulating CD62L expression of Tregs and mediating their migration to sites of inflammation, which may contribute to the development of therapeutic approaches for chronic kidney disease. The gene discussed is SELL; the disease is chronic kidney disease.